Nabila Mejdoub Rekik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nabila Mejdoub Rekik has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Mohamed Abid
Service d’endocrinologie, CHU Hédi Chaker Sfax, Sfax, Tunisie
3 shared publications N. Rekik
Service d’endocrinologie et diabétologie, CHU Hedi-Chaker, Sfax, Tunisie
3 shared publications- Nadia Charfi
Diabetology, Endocrinology Department - Hédi Chaker Sfax Hospital, Tunisia
3 shared publications F. Mnif
Service d’endocrinologie et diabétologie, CHU Hedi-Chaker, Sfax, Tunisie
2 shared publications- Faten Hadj Kacem
Service d’endocrinologie, CHU Hédi Chaker, Sfax, Tunisie
2 shared publications - Fatma Mnif
Service d’endocrinologie et diabétologie, CHU Hédi Chaker, Sfax, Tunisie
2 shared publications
Latest Publications
- Open Access
- 19 December 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (24) , 7525
Analysis of ProP1 Gene in a Cohort of Tunisian Patients with Congenital Combined Pituitary Hormone Deficiency
Background: Non-syndromic combined pituitary hormone deficiency (CPHD) occurs due to defects in transcription factors that govern early pituitary development and the specification of hormone-producing cells. The most common mutations are in the Prophet of Pit-1 (ProP1) gene. This work aims to (1) report findings of genetic analyses of Tunisian patients with non-syndromic CPHD and (2) describe their phenotype patterns and their evolution through life. Methods: Fifteen patients from twelve unrelated families with variable clinical phenotypes were included after excluding autoimmune and acquired forms of non-syndromic CPHD. Detailed pedigree charts and auxological, hormonal, radiological, and therapeutic details were recorded. Sanger sequencing was performed, and sequences were analyzed with a specific focus on coding and splice site regions of the ProP1 gene. Retained variants were classified using several in silico pathogenicity prediction tools and the VarSome platform. Results: We identified the common p.Arg73Cys mutation in seven patients from four unrelated pedigrees. We found a novel homozygous mutation (c.340C>T) in one sporadic case. This mutation generates a truncated ProP1 protein, predicted to be non-functional, lacking the last 112 codons (p.(Gln114Ter)). We confirmed by polymerase chain reaction (PCR) the absence of large exon deletions or insertions in the remaining sporadic patients (7/8). Conclusions: We report two mutations {one newly identified [p.(Gln114Ter)] and one previously reported (p.Arg73Cys)} in five unrelated Tunisian families with non-syndromic CPHD. This work is of clinical importance as it reports the high frequency of the p.Arg73Cys mutation in Tunisian CPHD families. Our study also illuminated the involvement of novel gene(s) in the emergence of non-syndromic CPHD.
- 19 December 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (24) , 7525
Open AccessAnalysis of ProP1 Gene in a Cohort of Tunisian Patients with Congenital Combined Pituitary Hormone Deficiency
Background: Non-syndromic combined pituitary hormone deficiency (CPHD) occurs due to defects in transcription factors that govern early pituitary development and the specification of hormone-producing cells. The most common mutations are in the Prophet of Pit-1 (ProP1) gene. This work aims to (1) report findings of genetic analyses of Tunisian patients with non-syndromic CPHD and (2) describe their phenotype patterns and their evolution through life. Methods: Fifteen patients from twelve unrelated families with variable clinical phenotypes were included after excluding autoimmune and acquired forms of non-syndromic CPHD. Detailed pedigree charts and auxological, hormonal, radiological, and therapeutic details were recorded. Sanger sequencing was performed, and sequences were analyzed with a specific focus on coding and splice site regions of the ProP1 gene. Retained variants were classified using several in silico pathogenicity prediction tools and the VarSome platform. Results: We identified the common p.Arg73Cys mutation in seven patients from four unrelated pedigrees. We found a novel homozygous mutation (c.340C>T) in one sporadic case. This mutation generates a truncated ProP1 protein, predicted to be non-functional, lacking the last 112 codons (p.(Gln114Ter)). We confirmed by polymerase chain reaction (PCR) the absence of large exon deletions or insertions in the remaining sporadic patients (7/8). Conclusions: We report two mutations {one newly identified [p.(Gln114Ter)] and one previously reported (p.Arg73Cys)} in five unrelated Tunisian families with non-syndromic CPHD. This work is of clinical importance as it reports the high frequency of the p.Arg73Cys mutation in Tunisian CPHD families. Our study also illuminated the involvement of novel gene(s) in the emergence of non-syndromic CPHD.
- Open Access
- 1 December 2019
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 18 (5) , 572-583
Successful Treatment of Insulin Allergy with Desensitization Therapy: A Case Report and Literature Review
Insulin therapy is an essential treatment for type 1 and uncontrolled type 2 diabetes mellitus (DM). Hypersensitivity reactions have been described since the first administration of insulin, the same as any other therapy. Despite being a rare situation nowadays, it requires careful intra-hospital monitoring and multidisciplinary management. Here, we present a case of a 57-year-old patient with type 2 DM, an average glycemic control, and both penicillin and insulin allergy. Heunderwent a desensitization protocol which allowed successfully dismiss him with intermediate-acting insulin.
- 1 December 2019
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 18 (5) , 572-583
Open AccessSuccessful Treatment of Insulin Allergy with Desensitization Therapy: A Case Report and Literature Review
Insulin therapy is an essential treatment for type 1 and uncontrolled type 2 diabetes mellitus (DM). Hypersensitivity reactions have been described since the first administration of insulin, the same as any other therapy. Despite being a rare situation nowadays, it requires careful intra-hospital monitoring and multidisciplinary management. Here, we present a case of a 57-year-old patient with type 2 DM, an average glycemic control, and both penicillin and insulin allergy. Heunderwent a desensitization protocol which allowed successfully dismiss him with intermediate-acting insulin.
- 24 August 2018
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 79 (4) , 347-348
Maladie de cushing récidivante traitée par cabergoline : à propos d’un cas
- 24 August 2018
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 79 (4) , 347-348
Maladie de cushing récidivante traitée par cabergoline : à propos d’un cas
- 9 September 2015
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 76 (4) , 466
L’hyperplasie bilatérale des surrénales : à propos de 29 cas
- 9 September 2015
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 76 (4) , 466
L’hyperplasie bilatérale des surrénales : à propos de 29 cas
- Open Access
- 3 October 2011
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 5 (1) , 490
Sheehan's syndrome with pancytopenia: a case report and review of the literature
Introduction: Sheehan's syndrome is defined by varying degrees of anterior pituitary deficiency due to postpartum ischemic necrosis of the pituitary gland after massive bleeding. It is a rare disorder in western countries and even in Tunisia. Hematologic abnormalities such as normochromic anemia have been reported in these patients. However, pancytopenia is rarely observed. Case presentation: We describe the case of a 48-year-old Tunisian woman with features of hypopituitarism. Laboratory tests showed pancytopenia that was completely reversed after adequate hormone replacement. Conclusion: Clinicians should consider the possibility of hypopituitarism as a cause of pancytopenia. This is an original case report that is of interest to hematologists, who should be aware of Sheehan's syndrome as a treatable etiology of pancytopenia for women.
- 3 October 2011
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 5 (1) , 490
Open AccessSheehan's syndrome with pancytopenia: a case report and review of the literature
Introduction: Sheehan's syndrome is defined by varying degrees of anterior pituitary deficiency due to postpartum ischemic necrosis of the pituitary gland after massive bleeding. It is a rare disorder in western countries and even in Tunisia. Hematologic abnormalities such as normochromic anemia have been reported in these patients. However, pancytopenia is rarely observed. Case presentation: We describe the case of a 48-year-old Tunisian woman with features of hypopituitarism. Laboratory tests showed pancytopenia that was completely reversed after adequate hormone replacement. Conclusion: Clinicians should consider the possibility of hypopituitarism as a cause of pancytopenia. This is an original case report that is of interest to hematologists, who should be aware of Sheehan's syndrome as a treatable etiology of pancytopenia for women.
- Open Access
- 27 December 2010
- Published by Hindawi Limited in Case Reports in Medicine
- Vol. 2010, 1-4
Adrenocortical Secreting Mass in a Patient with Gardner's Syndrome: A Case Report
Gardner's syndrome (GS) is a dysplasia characterized by neoformations of the intestine, soft tissue, and osseous tissue. Endocrine neoplasms have occasionally been reported in association with GS. Adrenal masses in GS are rare, and few have displayed clinical manifestations. In the current paper, The authors report a 37-year-old male patient with GS including familial adenomatous polyposis (FAP) and mandible osteoma who presented with an incidental adrenal mass. Computerized tomography adrenal scan identified bilateral masses. Functional analyses showed a hormonal secretion pattern consistent with pre-Cushing's syndrome. Other extraintestinal manifestations were hypertrophy of the pigmented layer of the retina and histiocytofibroma in the right leg. This paper describes a rare association of adrenocortical secreting mass in an old male patient with Gardner syndrome.
- 27 December 2010
- Published by Hindawi Limited in Case Reports in Medicine
- Vol. 2010, 1-4
Open AccessAdrenocortical Secreting Mass in a Patient with Gardner's Syndrome: A Case Report
Gardner's syndrome (GS) is a dysplasia characterized by neoformations of the intestine, soft tissue, and osseous tissue. Endocrine neoplasms have occasionally been reported in association with GS. Adrenal masses in GS are rare, and few have displayed clinical manifestations. In the current paper, The authors report a 37-year-old male patient with GS including familial adenomatous polyposis (FAP) and mandible osteoma who presented with an incidental adrenal mass. Computerized tomography adrenal scan identified bilateral masses. Functional analyses showed a hormonal secretion pattern consistent with pre-Cushing's syndrome. Other extraintestinal manifestations were hypertrophy of the pigmented layer of the retina and histiocytofibroma in the right leg. This paper describes a rare association of adrenocortical secreting mass in an old male patient with Gardner syndrome.
- 1 March 2010
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 71 (2) , 121-126
Hyperparathyroidism-jaw tumor syndrome: A case report
- 1 March 2010
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 71 (2) , 121-126
Hyperparathyroidism-jaw tumor syndrome: A case report